We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$372M
AUM Growth
+$48.1M
Cap. Flow
+$80.2M
Cap. Flow %
21.56%
Top 10 Hldgs %
69.34%
Holding
99
New
19
Increased
13
Reduced
16
Closed
23

Top Buys

Rank Stock Value
1
AKTS
Aktis Oncology
AKTS
+$61.4M
2
MPLT
MapLight Therapeutics
MPLT
+$12.1M
3
ENGN icon
enGene Therapeutics
ENGN
+$9.4M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$8.7M
5
EYPT icon
EyePoint Inc
EYPT
+$7.78M

Top Sells

Rank Stock Value
1
RPTX
Repare Therapeutics
RPTX
+$8.95M
2
PCOR icon
Procore
PCOR
+$6.86M
3
ROIV icon
Roivant Sciences
ROIV
+$5.71M
4
CGEM icon
Cullinan Oncology
CGEM
+$5.67M
5
CNTX icon
Context Therapeutics
CNTX
+$5.47M

Sector Composition

Rank Sector Weight
1 Healthcare 76.1%
2 Financials 13.79%
3 Consumer Discretionary 4.78%
4 Technology 2.41%
5 Real Estate 0.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAI
51
Caris Life Sciences
CAI
$4.39B
$84.2K 0.02%
+4,711
New +$103K
AMODW
52
Alpha Modus Holdings Warrant
AMODW
$74.2K 0.02%
1,854,665
– –
VKTX icon
53
CALL
Viking Therapeutics
VKTX
$4.04B
$68K 0.02%
+50,000
New +$1.61M
SHFS icon
54
SHF Holdings
SHFS
$1.25M
$63K 0.02%
75,897
– –
GOCO
55
DELISTED
GoHealth
GOCO
$61.6K 0.02%
+40,770
New +$77.9K
AEON icon
56
AEON Biopharma
AEON
$11.1M
$41.5K 0.01%
42,353
-1,042
-2% -$1.17K
BGLWW
57
Blue Gold Ltd Warrant
BGLWW
$914K
$35K 0.01%
175,000
– –
SLND.WS icon
58
Southland Holdings Warrants
SLND.WS
$34.4K 0.01%
860,302
– –
RDZNW icon
59
Roadzen Inc Warrants
RDZNW
$6.91M
$31.5K 0.01%
225,000
– –
GPCR icon
60
CALL
Structure Therapeutics
GPCR
$3.49B
$25K 0.01%
+100,000
New +$6.84M
BKSY.WS icon
61
BlackSky Technology Inc Warrants
BKSY.WS
$938K
$14K ﹤0.01%
350,000
– –
OLMA icon
62
CALL
Olema Pharmaceuticals
OLMA
$1.02B
$10K ﹤0.01%
+200,000
New +$4.45M
BDMDW
63
Baird Medical Investment Holdings Warrant
BDMDW
$9K ﹤0.01%
100,000
– –
DAICW
64
CID HoldCo Inc Warrants
DAICW
$116K
$8.89K ﹤0.01%
444,515
+144,515
+48% +$6.39K
DAVEW icon
65
Dave Inc Warrants
DAVEW
$34.3M
$7.76K ﹤0.01%
28,750
– –
TVGNW icon
66
Tevogen Bio Warrant
TVGNW
$9.45M
$6K ﹤0.01%
200,000
– –
KPLT icon
67
Katapult Holdings
KPLT
$32.8M
$5.74K ﹤0.01%
+5,421
New +$36K
SDSTW
68
Stardust Power Inc Warrant
SDSTW
$4.56M
$2.67K ﹤0.01%
16,666
-15,000
-47% -$2.88K
LIMNW
69
Liminatus Pharma Warrants
LIMNW
$382K
$2K ﹤0.01%
50,000
– –
PGYWW
70
Pagaya Technologies Ltd Warrants
PGYWW
$1.37M
$1.95K ﹤0.01%
48,661
– –
XBPEW
71
XBP Europe Holdings Warrant
XBPEW
$1.49K ﹤0.01%
24,778
– –
WALDW icon
72
Waldencast PLC Warrant
WALDW
$4.48M
$1.33K ﹤0.01%
33,333
– –
BTMWW
73
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$1K ﹤0.01%
50,000
– –
ASBPW
74
Aspire Biopharma Warrant
ASBPW
$519K
$1K ﹤0.01%
50,000
– –
BAERW icon
75
Bridger Aerospace Warrant
BAERW
– –
-25,000
Closed -$5K
1 2
3
4

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
MWM
Mindset Wealth Management Indianapolis, Indiana $372M AUM 50.62% 1-Year Est. Return
AWA
Acumen Wealth Advisors Chattanooga, Tennessee $372M AUM
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return

Blue Owl Capital Holdings's Q1 2026 Portfolio in Review

As of Q1 2026, Blue Owl Capital Holdings held 99 positions worth $372M, up 15% from $324M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Blue Owl Capital Holdings deployed $80.2M of net new capital in Q1 2026, opening 19 new positions and adding to 13 existing holdings. Its largest new stake was Aktis Oncology: 3,161,348 shares worth $56.6M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 64% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Cullinan Oncology, an estimated $5.67M trimmed.

  • Blue Owl Capital Holdings's largest Q1 2026 buy was Aktis Oncology: 3,161,348 shares worth $56.6M.
  • Blue Owl Capital Holdings added most to MapLight Therapeutics in Q1 2026, an estimated $12.1M increase.
  • Blue Owl Capital Holdings's biggest Q1 2026 reduction was Cullinan Oncology, cutting an estimated $5.67M.
  • Blue Owl Capital Holdings fully exited Repare Therapeutics in Q1 2026, selling an estimated $8.95M.
  • Blue Owl Capital Holdings's ten largest holdings make up 69% of its $372M portfolio in Q1 2026.
  • Blue Owl Capital Holdings opened 19 new positions and closed 23 in Q1 2026.
  • Blue Owl Capital Holdings's portfolio value rose 15% quarter-over-quarter to $372M.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2026, filed 14 May 2026.